Zheng Elizabeth X, Rossi Simona, Fontana Robert J, Vuppalanchi Raj, Hoofnagle Jay H, Khan Ikhlas, Navarro Victor J
Einstein Medical Center, 5401 Old York Road, Philadelphia, PA, 19141, USA.
University of Michigan School of Medicine, Ann Arbor, MI, USA.
Drug Saf. 2016 Aug;39(8):749-54. doi: 10.1007/s40264-016-0428-7.
Herbal and dietary supplements (HDS) have been increasingly recognized as a cause for acute liver injury (Navarro et al. Hepatology 60(4):1399-1408, 2014; Bailey et al. J Nutr 141:261-266, 2011). HDS products frequently contain numerous ingredients, and are marketed under various product names. A perusal of marketed weight loss products indicates that green tea extract (GTE) is a common ingredient in many. We aimed to describe the course and outcome of six patients who developed liver injury attributed to SLIMQUICK(®) weight loss products.
Patients with suspected drug-induced liver injury were enrolled in a prospective study of the Drug-Induced Liver Injury Network (DILIN) and causality was assessed by a panel of hepatologists. During the period under study, 6 of 1091 cases of liver injury were attributed to a SLIMQUICK(®) product and were assigned causality scores of probable, highly likely, or definite.
Six cases of acute liver injury attributed to SLIMQUICK(®) products were enrolled in the DILIN prospective study between 2007 and 2011. All were women aged 22 to 58 years. Two had a normal body weight and four were mildly obese (body mass index 22.9-32.2 kg/m(2)). All were taking SLIMQUICK(®) products for weight loss and no patient reported prior use. Laboratory tests revealed a hepatocellular pattern of injury, with initial alanine aminotransferase (ALT) levels above 1000 U/L in all but one patient. Three patients were hospitalized and one underwent successful liver transplantation. No patients died of liver injury. GTE and/or its component catechins were listed among the ingredients for five of the six products.
SLIMQUICK(®) products can lead to severe acute hepatocellular liver injury, which may result in transplantation. Given the frequency of GTE as a component in weight loss products, this ingredient should be studied further as a possible cause for liver injury.
草药和膳食补充剂(HDS)已越来越被认为是急性肝损伤的一个原因(纳瓦罗等人,《肝脏病学》60(4):1399 - 1408,2014年;贝利等人,《营养学杂志》141:261 - 266,2011年)。HDS产品通常含有多种成分,并以各种产品名称销售。对市场上的减肥产品进行一番研究表明,绿茶提取物(GTE)是许多产品中的常见成分。我们旨在描述6例因SLIMQUICK(®)减肥产品导致肝损伤患者的病程及结局。
疑似药物性肝损伤的患者被纳入药物性肝损伤网络(DILIN)的一项前瞻性研究,由一组肝病专家评估因果关系。在研究期间,1091例肝损伤病例中有6例归因于SLIMQUICK(®)产品,并被赋予可能、很可能或肯定的因果关系评分。
2007年至2011年期间,6例因SLIMQUICK(®)产品导致急性肝损伤的病例被纳入DILIN前瞻性研究。所有患者均为女性,年龄在22至58岁之间。2人体重正常,4人轻度肥胖(体重指数22.9 - 32.2kg/m²)。所有患者都在服用SLIMQUICK(®)产品以减肥,且无患者报告曾有过使用史。实验室检查显示为肝细胞损伤模式,除1例患者外,所有患者初始丙氨酸氨基转移酶(ALT)水平均高于1000U/L。3例患者住院治疗,1例成功接受肝移植。无患者死于肝损伤。6种产品中有5种的成分中列出了GTE和/或其成分儿茶素。
SLIMQUICK(®)产品可导致严重的急性肝细胞性肝损伤,这可能导致肝移植。鉴于GTE作为减肥产品成分的频率,应进一步研究该成分作为肝损伤可能原因的情况。